Humans with inherited heterozygous BRCA2 mutations have an increased risk of developing cancer; however, what triggers carcinogenesis in these individuals is unclear. Tan et al. find that environmental and metabolic aldehydes pose a threat to these individuals by promoting degradation of wild-type BRCA2 protein, thereby predisposing them to genomic instability and perhaps to cancer.
Inherited mutations in BRCA1 and BRCA2 genes increase the susceptibility of humans to breast, ovarian, prostate, pancreatic, and other types of cancers. Despite the extensive literature on BRCA2, a critical question remainsnamely, how does BRCA2 heterozygosity promote carcinogenesis? While biallelic disruption of BRCA2 in human cells causes increased sensitivity to genotoxic agents and chromosomal aberrations, genetically engineered mice that are heterozygous for mutant Brca2 are normal, with no measurable cellular DNA repair defects and minimal cancer predisposition (Evers and Jonkers, 2006; Venkitaraman, 2014) . Similarly, human carriers with heterozygous BRCA2-truncating mutations do not exhibit any clinical or obvious cellular phenotypes until they develop cancer. In this issue of Cell, Tan et al. (2017) uncover a novel mechanism for carcinogenesis and suggest that exposure to naturally occurring concentrations of formaldehyde or acetaldehyde may contribute to the carcinogenesis in individuals with heterozygous BRCA2 mutations.
Although both BRCA1 and BRCA2 have been implicated in many cellular processes such as cell cycle control, recombination, and transcription, their role is best understood during DNA double-strand break (DSB) repair by homologous recombination (HR) as guardians of genomic stability (Venkitaraman, 2014) . BRCA1 functions early in HR, where it interacts with nucleases, including CtIP and MRE11, and coordinates DNA end resection to form single-stranded DNA. BRCA2 subsequently loads the RAD51 recombinase onto the single-stranded DNA of the processed DSB to mediate HR (Thorslund et al., 2010) . BRCA1 and BRCA2 have also been implicated in stabilizing DNA replication forks (Lomonosov et al., 2003; Schlacher et al., 2011) . How environmental and metabolic factors affect the BRCA1 and BRCA2 functions and maintain genomic stability is an open question.
Reactive aldehydes such as formaldehyde and acetaldehyde are ubiquitously present in the environment and are also byproducts of cellular metabolism. Aldehydes are known to be genotoxic due to their capacity to form DNA and protein adducts, and the Fanconi anemia (FA)/ BRCA pathway is needed to combat this aldehyde-induced genotoxicity (Garaycoechea et al., 2012; Pontel et al., 2015) . Combined deficiency of both Adh5, a formaldehyde detoxifying enzyme, and Fancd2 results in severe DNA damage, bone marrow failure, and fatal malignancies in mice (Pontel et al., 2015) .
In the new work, Tan et al. (2017) initially observed that exposure of HeLa cells to formaldehyde results in DNA damage and stalled DNA replication in dividing cells. To model the heterozygous BRCA2 scenario occurring in carriers, they then created cells heterozygous for the clinically relevant BRCA2-truncating mutations 6174delT and 3036del4. As expected, these cells expressed 50% of wild-type BRCA2 protein and no detectable truncated BRCA2 protein, but they still exhibited normal functions, including HR-mediated DNA repair. Exposure of these cells to formaldehyde, but not to hydroxyurea, resulted in destabilization of replication forks in an MRE11-dependent manner (Schlacher et al., 2011) . Surprisingly, in normal cells expressing wild-type BRCA2 protein, formaldehyde, but not other DNA-damaging agents, caused a dose-dependent depletion of BRCA2 protein. Inhibitors of the proteasome prevented the depletion of BRCA2, indicating that formaldehyde promotes proteasomal degradation of wild-type BRCA2 protein. Importantly, formaldehyde exposure led to ''induced haploinsufficiency'' for BRCA2 in the BRCA2 heterozygote cells. Formaldehyde reduced the level of BRCA2 protein from a 50% level to a critically low 20% level. At this low BRCA2 protein level, the BRCA2 heterozygote cells exhibited many of the phenotypic features of a BRCA2 protein null cell, including many known DNA repair abnormalities. Complementation of these cells with wild-type BRCA2 restored BRCA2 functions and counteracted the formaldehyde-induced replication stress. Consistent with the role of BRCA2 as a custodian of chromosome integrity (Venkitaraman, 2014), formaldehyde-induced haploinsufficiency resulted in radial chromosomes in BRCA2 heterozygous cells, and inhibition of MRE11 ameliorated this effect. Similar to formaldehyde, acetaldehyde, an endogenous product of ethanol catabolism, also induced haploinsufficiency for BRCA2 and replication fork instability in BRCA2 heterozygous cells.
R-loops, the structures that contain an RNA-DNA hybrid and displaced singlestranded DNA, can form during transcription. Unscheduled R-loops, formed due to defects in RNA processing, promote DNA breaks and genomic instability. Interestingly, unscheduled R-loops are known to accumulate after biallelic loss of BRCA2 (Bhatia et al., 2014) . Tan et al. (2017) , therefore, studied the contribution of R-loops in formaldehyde-mediated genomic instability. Interestingly, overexpression of ribonuclease H1 (RNase H1), known to cleave R loops, ameliorated the formaldehyde-induced replication stress and chromosomal aberrations of BRCA2 heterozygous cells, suggesting that R-loops mediate the formaldehydeinduced cellular anomalies.
Taken together, the study by Tan et al. (2017) demonstrates that naturally occurring aldehyde concentrations can destabilize DNA replication forks, leading to genomic instability in BRCA2 heterozygous cells by selectively depleting the remaining wild-type BRCA2 protein to critically low levels. The results support a new model (Figure 1 ) for carcinogenesis in individuals who carry a pathogenic truncating mutation in one of their BRCA2 alleles and predict that aldehydes may pose a threat to these individuals.
This study has several important public health implications and highlights the detrimental effects of environmental, endogenous, and dietary aldehydes. The tissue-specific differences in terms of aldehyde accumulation and sensitivity toward aldehydes may contribute to the development of specific types of cancers (e.g., breast, ovarian, prostate) in BRCA2 heterozygous carrier population. In addition to BRCA2, other genetic mutations may also trigger the aldehyde effects in this population. For example, individuals who are heterozygous for ALDH2, a gene encoding an enzyme responsible for detoxifying acetaldehyde, may have an increased risk for cancer, especially in the setting of BRCA2 heterozygosity. Importantly, the risk of cancer in BRCA2 heterozygote carriers may be reduced by dietary aldehyde scavengers such as Resveratrol. These individuals may also benefit by limiting alcohol consumption.
While some mutant alleles of BRCA2, such as those encoding a truncated protein, are clearly pathogenic, other variant alleles contain a missense mutation, which may or may not be pathogenic. For instance, an individual carrying a BRCA2 variant missense allele has an unclear risk of cancer. The results from Tan et al. (2017) predict that a subset of missense mutations may also be identified as truly pathogenic using an ex vivo formaldehyde challenge assay in peripheral blood lymphocytes from such individuals. Another recent study has identified a cellular phenotype of BRCA1 heterozygotes and has shown that the primary cells from these carriers are defective in a stalled replication fork repair function (Pathania et al., 2014) .
The study by Tan et al. (2017) poses additional new questions. First, it will be important to identify the cellular enzymes that regulate degradation of BRCA2. Inhibition of this process may prevent BRCA2 depletion and provide a chemopreventative strategy for heterozygote carriers. Second, formaldehyde may pose a risk to heterozygote carriers of other mutant DNA repair genes in the FA/BRCA network. Third, other environmental or metabolic factors may induce haploinsufficiency in BRCA2 carriers. Fourth, it will be interesting to determine whether induced haploinsufficiency precedes loss-of-heterozygosity (LOH) at the BRCA2 locus. In summary, the new study provides important insights into a potential mechanism of carcinogenesis in heterozygous BRCA2 mutation carriers and suggests that aldehydes may be harmful to the health of these individuals. BRCA2 protein is susceptible to aldehyde-mediated degradation. In cells from normal individuals with wild-type BRCA2, the reduction in BRCA2 protein levels after aldehyde exposure do not fall below the threshold of adequacy. In BRCA2 heterozygous carriers, however, BRCA2 protein levels are already reduced by 50%, and aldehyde exposure causes further reduction (to 20% of wild-type levels), resulting in ''induced haploinsufficiency'' for BRCA2. Aldehyde-induced BRCA2 haploinsufficiency provokes replication fork instability, formation of RNA-DNA hybrids (R-loops), and chromosomal aberrations. These aldehyde-induced anomalies may trigger carcinogenesis in BRCA2 heterozygous carriers. Regulatory T cells (Tregs) play a central role in the maintenance of self tolerance and immune homeostasis (Plitas and Rudensky, 2016) . Although Tregs are essential in limiting autoimmunity and in finetuning inflammation after infection, they also limit anti-tumor immunity and allow tumor progression (Tanaka and Sakaguchi, 2017) . Indeed, the number of Tregs present in the tumor and, in particular, a decreased ratio of effector CD8 + T cells to Tregs correlates with poor prognosis in multiple cancers (Li et al., 2010) . However, the exact molecular basis of Treg function, Tregs' role in tumor tissue, and, in particular, development of means to deplete the appropriate Treg subsets while limiting autoimmunity remain elusive.
In previous work, Vignali and colleagues found that neuropilin-1 (Nrp1) is expressed by the majority of intratumoral Tregs and is key to their suppressive function within the tumor given that they become functionally unstable and lose their suppressive ability when Nrp1 is inactivated (Delgoffe et al., 2013) . As a result, mice with deletion of Nrp1 in Tregs are resistant to B16 melanoma tumor implantation and do not display any autoimmune or inflammatory disease.
Treg functional instability and lineage plasticity have captured the attention of the Treg field and have generated some degree of controversy (Hori, 2014; Overacre and Vignali, 2016) . Although previous work has clearly shown the importance of Nrp1 in Treg fragility, the impact and relevance of this finding in human cancer has remained unclear.
To begin to answer this question, Overacre-Delgoffe et al. (2017 [this issue of Cell]) asked whether NRP1 is expressed in the Tregs of patients with melanoma and head and neck squamous cell carcinoma (HNSCC). While very few Tregs in healthy donors express NRP1, a significant but variable fraction of intratumoral Tregs in patients with melanoma (3%-90%) or HNSCC (35%-90%) are NRP1+. This variation in frequency of NRP1+ Tregs raises the question of whether NRP1+ expression in only a subset of Tregs within the tumor microenvironment is relevant for tumor growth. To address this question, the authors set up a clever system by which they can test the impact of Nrp1 loss in a subset of Tregs on the function of the remaining wild-type (WT) counterparts and on the tumor microenvironment (Figure 1) 
